Impact of relative dose intensity on bone marrow suppression induced by S-1: retrospective observational study

BACKGROUND: S-1 (a combination of tegafur, gimeracil, and oteracil) is used to treat various cancers. Bone marrow suppression is a dose-limiting toxicity of S-1. The relationship between relative dose intensity (RDI) and bone marrow suppression has not been investigated. Hence, we aimed to elucidate...

Descripción completa

Detalles Bibliográficos
Autores principales: Hirai, Toshinori, Ogawa, Ryuichi, Yamaga, Ryosuke, Itoh, Toshimasa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6276246/
https://www.ncbi.nlm.nih.gov/pubmed/30524750
http://dx.doi.org/10.1186/s40780-018-0127-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6276246/
https://www.ncbi.nlm.nih.gov/pubmed/30524750
http://dx.doi.org/10.1186/s40780-018-0127-x

Ejemplares similares